Quality of Life of Children with Congenital Heart Diseases: A Multicenter Controlled Cross-Sectional Study

P Amedro1,2,3, R Dorka4, S Moniotte5

  • 1Pediatric and Congenital Cardiology Department, University Hospital, Montpellier, France. p-amedro@chu-montpellier.fr.

Insights

Children with congenital heart disease (CHD) report similar quality of life (QoL) to healthy peers in most areas. However, parents perceive significant QoL impairments in CHD children across multiple domains.

Area of Science:

  • Pediatrics
  • Cardiology
  • Quality of Life Research

Background:

  • Congenital heart diseases (CHD) are common birth defects impacting children's health.
  • Assessing health-related quality of life (QoL) is crucial for understanding the holistic well-being of children with CHD.
  • Previous studies highlight potential QoL challenges in pediatric populations with chronic conditions.

Purpose of the Study:

  • To evaluate and compare the health-related quality of life (QoL) in children with congenital heart diseases (CHD) against a control group of healthy children.
  • To investigate the influence of disease severity on the QoL of children with CHD.
  • To differentiate between self-reported and parent-reported QoL in this pediatric cohort.

Main Methods:

  • Prospective recruitment of 282 children (8-18 years) with CHD from French and Belgian tertiary centers.
  • Inclusion of 180 age-matched healthy children from French schools as controls.
  • Utilized the validated KIDSCREEN-52 for self-reported QoL and KIDSCREEN-27 for parent-reported QoL.

Main Results:

  • Self-reported QoL in children with CHD was lower than controls in physical well-being, financial resources, social support, and autonomy.
  • Parent-reported QoL was diminished in CHD children for physical well-being, psychological well-being, social support, and school environment.
  • Disease severity impacted self-reported physical well-being, financial resources, and social support, and parent-reported physical and psychological well-being, social support, and school environment.

Conclusions:

  • While children with CHD perceive their QoL similarly to healthy peers in many aspects, parental reports indicate significant impairments.
  • Physical well-being and social support are key areas affected, with disease severity playing a role.
  • Findings underscore the importance of considering both patient and caregiver perspectives in assessing QoL for children with CHD.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
754
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
681
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
388
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
482
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
599